T. Rowe Price Associates
AGN

T. Rowe Price Associates’s Allergan Inc AGN Stock Holding History

T. Rowe Price Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18,285,285
Closed -$3.89B – 2629
2014
Q4 		$3.89B Buy
18,285,285
+68,276
+0.4% +$13.6M 0.83% 15
2014
Q3 		$3.25B Buy
18,217,009
+2,297,605
+14% +$382M 0.71% 18
2014
Q2 		$2.69B Buy
15,919,404
+8,326,553
+110% +$1.3B 0.58% 29
2014
Q1 		$942M Buy
7,592,851
+1,946,977
+34% +$237M 0.21% 120
2013
Q4 		$627M Buy
5,645,874
+2,719,795
+93% +$260M 0.14% 173
2013
Q3 		$265M Sell
2,926,079
-562,014
-16% -$50.5M 0.07% 342
2013
Q2 		$294M Buy
+3,488,093
New +$362M 0.08% 300

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

T. Rowe Price Associates's AGN Position: Q1 2015 in Review

T. Rowe Price Associates sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 18,285,285 shares — an estimated $3.89B sold.

T. Rowe Price Associates first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $3.89B in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • T. Rowe Price Associates reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 18,285,285 Allergan Inc shares in Q1 2015, an estimated $3.89B.
  • T. Rowe Price Associates first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • T. Rowe Price Associates's Allergan Inc position peaked at $3.89B in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.